State Key Laboratory of Respiratory Disease for Allergy, School of Medicine, Shen Zhen University, Shen Zhen 518060, China; Institute of Allergy and Immunology, School of Medicine, Shen Zhen University, Shen Zhen 518060, China.
Int Immunopharmacol. 2013 Nov;17(3):576-84. doi: 10.1016/j.intimp.2013.06.016. Epub 2013 Jul 5.
BACKGROUND: The prevalence of food allergy has increased dramatically during the last three decades, but currently there was no effective therapy except avoidance of allergen. This study aimed to investigate the effect of a modified Chinese herbal formula, Formula-3, on mast cell degranulation and the anti-allergic activity in both animal and cell models. METHODS: With OVA-sensitized food allergic model in Brown-Norway rats, we checked tissue injury in the small intestines by H&E staining. The Th2 cytokine levels and IgE production in serum or supernatant of the intestinal mucosa homogenates were analyzed by ELISA. Meanwhile, rat peritoneal mast cell activation and degranulation were examined by Toluidine Blue Stain and the release of histamine was measured. Furthermore, the regulation of Formula-3 on Ca(2+) mobilization was investigated by probing intracellular Ca(2+) with fluo-4 fluorescence. The direct effect of Formula-3 on mast cell stabilization was also studied in RBL-2H3 cell line. RESULTS: In vivo Formula-3 administration significantly reduced tissue damage in the small intestines of rat and suppressed Th2 cytokine secretion and IgE production. We demonstrated that Formula-3 treatment significantly suppressed FcεR1-mediated mast cell degranulation no matter in OVA-challenged allergic rats or IgE-sensitized RBL-2H3 cell line. Furthermore, Formula-3 significantly decreased Ca(2+) influx through store-operated calcium channels (SOCs) evoked by dinitrophenyl-BSA or thapsigargin in mast cells. CONCLUSION: Taken together, our data indicate that Formula-3 stabilizes mast cells by suppressing FcεR1-induced Ca(2+) mobilization mainly through inhibiting Ca(2+) entry via SOCs, thus exerting a protective effect against OVA-sensitized food allergy.
背景:在过去的三十年中,食物过敏的患病率急剧上升,但目前除了避免过敏原外,还没有有效的治疗方法。本研究旨在探讨改良中药配方 3 号(Formula-3)对肥大细胞脱颗粒的影响及其在动物和细胞模型中的抗过敏活性。
方法:通过 OVA 致敏的食物过敏模型,我们通过 H&E 染色检查小肠组织损伤。通过 ELISA 分析血清或肠黏膜匀浆上清液中 Th2 细胞因子水平和 IgE 产生。同时,通过甲苯胺蓝染色检查大鼠腹腔肥大细胞活化和脱颗粒,测量组胺释放。此外,通过荧光探针 fluo-4 检测细胞内 Ca2+,研究 Formula-3 对 Ca2+动员的调节作用。还在 RBL-2H3 细胞系中研究了 Formula-3 对肥大细胞稳定化的直接作用。
结果:体内给予 Formula-3 可显著减轻大鼠小肠组织损伤,抑制 Th2 细胞因子分泌和 IgE 产生。我们证明,无论在 OVA challenged 过敏大鼠还是 IgE 致敏的 RBL-2H3 细胞系中,Formula-3 治疗均显著抑制 FcεR1 介导的肥大细胞脱颗粒。此外,Formula-3 显著降低了二硝基苯-BSA 或 thapsigargin 通过储存操纵钙通道(SOCs)引起的肥大细胞内 Ca2+内流。
结论:综上所述,我们的数据表明,Formula-3 通过抑制 SOCs 介导的 Ca2+内流来稳定肥大细胞,从而抑制 FcεR1 诱导的 Ca2+动员,从而对 OVA 致敏的食物过敏发挥保护作用。
Int Immunopharmacol. 2013-7-5
World J Gastroenterol. 2013-7-7
Int Arch Allergy Immunol. 2017
J Allergy Clin Immunol. 2010-12
Clin Exp Allergy. 2025-8
Am J Transl Res. 2019-9-15
Clin Rev Allergy Immunol. 2019-8
Evid Based Complement Alternat Med. 2016
Allergy Asthma Clin Immunol. 2014-12-20